The Dermatological Drugs market in Cuba has been developing in a unique way due to various factors.
Customer preferences: Cuban customers have been showing a preference for natural and traditional remedies for dermatological issues. This trend is partly due to the limited availability of modern dermatological drugs in the country. Many customers prefer to use locally sourced natural remedies such as aloe vera and honey, which are believed to have healing properties. This preference for natural remedies has resulted in a limited market for modern dermatological drugs in Cuba.
Trends in the market: The market for modern dermatological drugs in Cuba is relatively small due to the limited availability and high cost of these drugs. However, there has been a growing demand for these drugs in recent years. This is partly due to an increase in skin conditions such as eczema and psoriasis, which are often treated with modern dermatological drugs. Additionally, there has been an increase in medical tourism to Cuba, which has resulted in a growing demand for modern dermatological drugs from foreign patients.
Local special circumstances: Due to the US embargo on Cuba, the country has limited access to modern medical technology and drugs. This has resulted in a limited market for modern dermatological drugs in Cuba. Additionally, the Cuban government has a national healthcare system that provides free healthcare to all citizens. While this system provides basic medical care, it often lacks access to modern drugs and technology.
Underlying macroeconomic factors: The Cuban economy has been struggling in recent years due to a variety of factors, including a decline in tourism and a reduction in exports. This has resulted in a limited budget for healthcare and a limited ability to import modern drugs and technology. Additionally, the US embargo on Cuba has limited the country's ability to trade with other countries and access modern medical technology and drugs. These macroeconomic factors have contributed to the limited market for modern dermatological drugs in Cuba.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
